DHT Holdings And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – DHT Holdings (DHT), Evertec (EVTC), ProLogis (PLD) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. DHT Holdings (DHT)

42.7% sales growth and 18.39% return on equity

DHT Holdings, Inc., through its subsidiaries, owns and operates crude oil tankers primarily in Monaco, Singapore, Oslo, and Norway. As of March 17, 2021, it had a fleet of 28 very large crude carriers with a capacity of 8,660,835 deadweight tons. The company was founded in 2005 and is headquartered in Hamilton, Bermuda.

Earnings Per Share

As for profitability, DHT Holdings has a trailing twelve months EPS of $1.14.

PE Ratio

DHT Holdings has a trailing twelve months price to earnings ratio of 8.98. Meaning, the purchaser of the share is investing $8.98 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.39%.

2. Evertec (EVTC)

15.7% sales growth and 19.52% return on equity

EVERTEC, Inc. engages in transaction processing business in Latin America and the Caribbean. The company operates through Payment Services – Puerto Rico & Caribbean; Payment Services – Latin America; Merchant Acquiring; Business Solutions, and Corporate and Other segments. It provides merchant acquiring services, which enable point of sales and e-commerce merchants to accept and process electronic methods of payment, such as debit, credit, prepaid, and electronic benefit transfer (EBT) cards. The company also offers payment processing services that enable financial institutions and other issuers to manage, support, and facilitate the processing for credit, debit, prepaid, automated teller machines, and EBT card programs; credit and debit card processing, authorization and settlement, and fraud monitoring and control services to debit or credit issuers; and EBT services. In addition, it provides business process management solutions comprising core bank processing, network hosting and management, IT consulting, business process outsourcing, item and cash processing, and fulfillment solutions to financial institutions, and corporate and government customers. Further, the company owns and operates the ATH network, an automated teller machine and personal identification number debit networks. It manages a system of electronic payment networks that process approximately three billion transactions. The company sells and distributes its services primarily through direct sales force. It serves financial institutions, merchants, corporations, and government agencies. EVERTEC, Inc. was founded in 1988 and is headquartered in San Juan, Puerto Rico.

Earnings Per Share

As for profitability, Evertec has a trailing twelve months EPS of $1.51.

PE Ratio

Evertec has a trailing twelve months price to earnings ratio of 25.21. Meaning, the purchaser of the share is investing $25.21 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.52%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 18.8%, now sitting on 661.88M for the twelve trailing months.

3. ProLogis (PLD)

13.2% sales growth and 6.53% return on equity

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At September 30, 2023, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (114 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 6,700 customers principally across two major categories: business-to-business and retail/online fulfillment.

Earnings Per Share

As for profitability, ProLogis has a trailing twelve months EPS of $3.14.

PE Ratio

ProLogis has a trailing twelve months price to earnings ratio of 37.78. Meaning, the purchaser of the share is investing $37.78 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.53%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 8.2%, now sitting on 8.17B for the twelve trailing months.

4. Cinemark Holdings (CNK)

12.9% sales growth and 40.81% return on equity

Cinemark Holdings, Inc., together with its subsidiaries, engages in the motion picture exhibition business. As of October 8, 2021, it operated 521 theatres with 5,864 screens in the United States, and South and Central America. The company was founded in 1984 and is headquartered in Plano, Texas.

Earnings Per Share

As for profitability, Cinemark Holdings has a trailing twelve months EPS of $0.6.

PE Ratio

Cinemark Holdings has a trailing twelve months price to earnings ratio of 24.35. Meaning, the purchaser of the share is investing $24.35 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.81%.

5. Boston Scientific (BSX)

8% sales growth and 6.68% return on equity

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Earnings Per Share

As for profitability, Boston Scientific has a trailing twelve months EPS of $0.82.

PE Ratio

Boston Scientific has a trailing twelve months price to earnings ratio of 66.83. Meaning, the purchaser of the share is investing $66.83 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.68%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 11.3%, now sitting on 13.76B for the twelve trailing months.

Yearly Top and Bottom Value

Boston Scientific’s stock is valued at $54.80 at 09:22 EST, under its 52-week high of $56.22 and way higher than its 52-week low of $44.35.

Volume

Today’s last reported volume for Boston Scientific is 1770120 which is 77.85% below its average volume of 7993910.

6. PayPal (PYPL)

6.9% sales growth and 18.82% return on equity

PayPal Holdings, Inc. operates a technology platform that enables digital payments on behalf of merchants and consumers worldwide. The company provides payment solutions under the PayPal, PayPal Credit, Braintree, Venmo, Xoom, PayPal Zettle, Hyperwallet, PayPal Honey, and Paidy names. Its payments platform allows consumers to send and receive payments in approximately 200 markets and in approximately 150 currencies, withdraw funds to their bank accounts in 56 currencies, and hold balances in their PayPal accounts in 25 currencies. The company was founded in 1998 and is headquartered in San Jose, California.

Earnings Per Share

As for profitability, PayPal has a trailing twelve months EPS of $3.35.

PE Ratio

PayPal has a trailing twelve months price to earnings ratio of 17.59. Meaning, the purchaser of the share is investing $17.59 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.82%.

Previous days news about PayPal(PYPL)

  • According to VentureBeat on Friday, 8 December, "In a turbulent year for venture capital investing, Mine countered the trend with a Series B $30 million funding round co-led by PayPal Ventures and Battery Ventures, with notable investment from Nationwide Ventures."

Leave a Reply

Your email address will not be published. Required fields are marked *